Crotalus oreganus abyssus is a rattlesnake that is usually found in the Grand Canyon, United States of America. Knowledge regarding the composition of C. o. abyssus venom is scarce. New natriuretic peptides (NPs) have been isolated and characterized from the venoms of members of the Crotalinae family. The NP family comprises three members, ANP (atrial natriuretic peptide), BNP (b-type natriuretic peptide) and CNP (c-type natriuretic peptide), and has an important role in blood pressure regulation and electrolyte homeostasis. The aim of the present study was to characterize a novel natriuretic-like peptide (Coa NP2), isolated from C. o. abyssus venom. The Coa NP2 presents an average molecular mass of 3419.88 Da (theoretical average molecular mass 3418.94 Da, monoisotopic molecular mass 3416.66 Da and theoretical PI 7.78) and its amino acid sequence presents the loop region that is characteristic of natriuretic peptides. The peptide has 32 amino acids and its complete sequence is SYGISSGCFGLKLDRIGTMSGLGCWRLLQDSP. Coa NP2 is a natriuretic peptide of the ANP/BNP-like family, since the carboxyterminal region of CNP has its own NP domain. We demonstrate, herein, that Coa NP2 produces a dose-dependent decrease in mean arterial pressure in rats, followed by significant increases in concentrations of markers of nitric oxide formation measured in the plasma and vasorelaxation in a thoracic aortic ring bath. The structural and biological aspects confirm Coa NP2 as a new natriuretic peptide, isolated from snake venom.
Introduction
Snake venoms are protein mixtures that act in several physiological systems of their prey or victims. Some effects related to venomous snake bites can promote tissue damage, myotoxicity, hemorrhagic effects, and inflammation amongst others [2, 6, 8] . Many snake venoms contain toxins that produce interesting cardiovascular effects, such as hypotension, or bradykinin-potentiating peptides [15, 28] , or renal effects [10, 39] . Natriuretic peptides (NPs) are body fluid volume modulators that play important roles in natriuresis and dieresis [23] . The three mammalian NPs, atrial natriuretic peptide (ANP), brain or b-type natriuretic peptide (BNP) and cardiac or c-type natriuretic peptide (CNP), have been extensively investigated for their use as therapeutic agents in the treatment of cardiovascular diseases [1, 3, 18, 22, 23, 30, 31] .
Human NPs form a family of structural-similar polypeptides. They have a highly conserved 17-residue intra-molecular disulfide loop (CFGxxxDRIxxxSGLGC), which is important for their biological activity. Within this cyclic structure, nine amino acids are identical in all three classes of NPs. However, they differ from each other in that they have different numbers of amino acid residues at the N-and C-terminal portion of the peptide [11, 20, 23] . In 1992, Schweitz et al. [33] identified the first venom NP from the green mamba snake, Dendroaspis angusticeps, and named it as the Dendroaspis natriuretic peptide (DNP). Although DNP shares similarity with ANP, it has a distinctly different C-terminal tail. Ho et al. [17] identified and characterized a NP from the South American coral snake, Micrurus corallines, and reported that it shows some similarities with DNP. Recently, another NP isolated from the venom of the Lachesis muta snake (Lm-CNP) was identified with a similar structure to human CNP [35] . In addition, a cDNA sequence of Bj-CNP from Bothrops jararaca has also been shown to encode a CNP-like NP and seven bradykinin potentiation [28] . On the other hand, knowledge regarding the composition of Crotalus oreganus abyssus venom is scarce [24] . From previous experiments in our laboratory in which we have studied the effects of peptides isolated from C. o. abyssus venom, we showed the presence of a natriuretic peptide in its venom (now called Coa NP1) that produced hypotensive and vasorelaxation effects [5] . The aim of the present study was to identify and investigate the systemic and vascular effects of a new natriuretic peptide isolated from C. o. abyssus venom (Coa NP2).
Materials and methods
All reagents were purchased from Aldrich or Sigma Co. (USA). C. o. abyssus (Coa) venom was obtained from The National Natural Toxins Research Center (NNTRC) of Texas A&M UniversityKingsville (Kingsville, TX, USA).
2.1. Isolation and purification of the natriuretic peptide from C. o. abyssuss C. o. abyssus (Coa) whole venom was submitted to an FPLC molecular exclusion chromatographic column packed with Sephadex 75 (Akta Primer, GE, USA), exactly as described in [5] . In this separation, five peaks were observed (I-V) (Fig. 1A) . Only fraction V presented a hypotensive effect. To perform a better study and for separation of peptides and proteins, fraction V was then submitted to ultra-filtration using the MidJet apparatus (Ge Healthcare, USA), equipped with the UFP-10-C-MM01A cartridge, and a superficial area of 26 cm 2 , cut off: 10,000 Da (Ge Healthcare, USA). The filtrate presented hypotensive effects and was lyophilized and stored at −20 • C, until use.
The filtrate was subjected to reverse phase HPLC (model 2010, Shimadzu, Japan) using an analytical C5 column (Supelco, 250 mm × 4.6 mm), which was previously equilibrated with buffer A (0.1% TFA). The filtrate (10 mg) were dissolved completely in buffer A (0.1% TFA), centrifuged at 5000 × g and then loaded onto a reverse-phase column. The peptides were purified using a linear gradient of buffer B concentration (66% acetonitrile in buffer A) and the chromatographic UV monitoring was carried out at 216 nm [6, 7] . For electrophoresis, Tricine PAGE-SDS was used for characterization of low molecular weight proteins and peptides [32] . Each peak or peak group was tested for its action on blood pressure and Coa NP2 showed positive results.
Sequencing of the Coa NP
Two milligrams of the purified peptide were dissolved in 200 l of a 6 mol/l guanidine chloride solution containing 0.4 mol/l of Tris-HCl and 2 mmol/l EDTA (pH 8.15). Nitrogen was blown over the top of the protein solution for 15 min, before reducing with DTT (6 M, 200 l). This solution was incubated in the dark at 37 • C for 1 h and desalted using a Sephadex G25 column (0.7 cm × 12 cm) with 1 mol/l acetic acid buffer. The reduced peptide was sequenced using an automatic peptide sequencer (890C automatic sequencer, [21] Beckman, USA). The phenylthyoidantoin (PTH) amino acids were identified by comparing their retention times to the 20 PTH amino acid standards [2] .
MALDI-TOF mass spectrometric analysis (MS)
The molecular mass of isolated Coa-NP was analyzed by MALDI-TOF mass spectrometry using a Voyager-DE PRO MALDI-TOF apparatus (Applied Biosystems, USA). One microliter of sample in 0.1% TFA was mixed with 2 l of 3,5-dimethoxy-4-hydroxycinnamic acid (matrix sinapinic acid). The matrix was prepared with 30% acetonitrile and 0.1% TFA. Conditions of analysis: (1) acceleration of voltage 25 kV; (2) laser fixation at 2890 mJ/com2; (3) delay of 300 ns; and (4) linear analysis mode [2] .
Animals: rats, conditions and ethical statements
Male Wistar rats (250-300 g) were used in this study and were maintained under specific pathogen-free conditions. The animals were housed in laminar-flow cages maintained at a temperature of 22 ± 2 • C and a relative humidity of 50-60%, under a 12:12 h light-dark cycle. Animal experiments were performed in accordance with the ethical guidelines of Helsinki Declaration (1975), the Institutional Animal Care and Use Ethical Committee of State University of Campinas (UNICAMP) and the Federal University of São João Del Rei (UFSJ), both Brazilian universities.
Blood pressure measurements
Male Wistar rats were anesthetized with 50 mg/kg pentobarbital and, thereafter, the right carotid artery was cannulated with a polyethylene tube (PE50), under anesthetic conditions (50 mg/kg of pentobarbital). Mean arterial pressure (MAP) was continuously recorded for 30 min using a pressure transducer (P23 Gould Statham, USA) connected to a polygraph (Narco Biosystems,). After this time, solutions used as controls and tests (Coa NP2; 0.25 or 0.50 g/ml) were injected (every 15 min) through a catheter implanted in the jugular vein Each measurement was compared with an isovolumetric injection of saline [10] . Mean arterial pressure (MAP) was calculated by the following formula:
where MAP is the mean arterial pressure; SP is the systolic pressure and DP is the diastolic pressure.
Aortic ring experiments
Male Wistar rats (250-300 g) were killed and the descending thoracic aorta was rapidly removed and flushed with physiological solution. After removal of adhering fat and connective tissue, 5 mm rings were obtained from preparations of endothelium-intact (e + ) and endothelium-denuded (e − ). This latter preparation was carried out by gently rubbing the vessel's lumen and mounting the aortic rings under 1 g resting tension, between two stainless steel hooks, in organ baths (37 • C, pH 7.4) and bubbling with a carbogenated (95% O 2 and 5% CO 2 ) physiological salt solution of the following composition (mM): NaCl: 118.4; NaHCO 3 : 25; glucose: 11; KCl: 4.7; MgSO 4 : 1.2; KH 2 PO 4 : 1.2; and CaCl 2 : 2.5. The lower hook was attached to a tissue holder and the upper hook was connected to an isometric force displacement transducer (F-60, Narco Biosystems, Houston, TX, USA); the responses were recorded though a 4-channel polygraph (Narco BioSystems, TX, USA). The aortic rings were submitted to a tension of 1 g during a 60-min equilibration period and were considered to have an intact functional endothelium when acetylcholine (1 mol/l) produced a relaxation of more than 80%. Relaxation was calculated as a percentage of the contraction induced by phenylephrine (PE; 0.1 M) and concentration-response curves were performed for NP isolated by C. o. abyssus, Coa NP2 (10 −11 to 10 −7 M), in both e + and e − aortic rings. In another set of experiments, concentration-response curves for Coa NP2 (10 −11 to 10 −7 M) were compared with phenylephrine precontracted endothelium-intact tissues in the absence or presence of ISATIN (1 M, a potent guanylate cyclase-coupled atrial natriuretic peptide receptor type A antagonist) [13, 25] and incubated for 30 min. In the last set of experiments, concentration-response curves for Coa NP2 (10 −11 to 10 −7 M) were performed on aortic rings precontracted with isosmotic high-potassium (K + 80 mM) Krebs-Henseleit solution [10, 12] .
Determination of plasma NOx (nitrate + nitrite) concentrations
After the infusion of Coa NP2 extracted from C. o. abyssus and the blood pressure assessment, levels of plasma nitrite were measured by colorimetric Griess methods. In these assays, 50 l of the samples were incubated with the same volume of Griess reagent (1% sulfanilamide, 0.1% naphthylethylenediamine dihydrochloride in 5% phosphoric acid). Nitrite levels were determined by comparison with a standard curve obtained by incubating sodium nitrate (10-200 M) with reductase, buffered and measured at 550 nm in a multiwell plate reader (HIDEX, Shimadzu, Japan). The results were reported as micromolar concentrations (M) of NO 2 [26] .
Measurement of plasma nitrite concentrations
After the infusion of Coa NP2 extracted from C. o. abyssus and the blood pressure assessment, levels of plasma nitrite were analyzed in duplicate for their nitrite content using an ozone-based reductive chemiluminescence assay as previously described [27] . Briefly, to measure nitrite concentrations in plasma, 100 l of plasma samples were injected into a solution of acidified tri-iodide, purging with nitrogen in-line with a gas-phase chemiluminescence NO analyzer (Sievers Model 280 NO analyzer, Boulder, CO). Approximately 8 ml of tri-iodide solution (2 g potassium iodide and 1.3 g iodine dissolved in 40 ml water with 140 ml acetic acid) was placed in the purge vessel, into which plasma samples were injected. The triiodide solution reduces nitrites to NO gas, which is detected by the NO analyzer.
Theoretical model: computational methods
After the release of the primary sequence of Coa NP2, a set of homology modeling studies was carried out in order to obtain tertiary structure information following a previously described protocol [14] . Initially, a template search was performed by SWISS-MODEL workspace, which identified several close homologue-resolved structures by SWISS-MODEL Template Library (SMTL). As the alignment between the target and the templates sequences showed high similarity, the automated mode was chosen to build the tridimensional structure target. The models were then refined with the AMBER 9.0 package. The models built were prepared using Leap and submitted to Sander software for geometry refinement. The models were fully optimized with 1000 steps of steep descent followed by 4000 steps of conjugate gradient. The minimization processes were performed with a cutoff value of 14Å for non-bonded interactions, implicit solvent generalized Born model, and using a ff03 force field [9] . The figures for 3D structure were prepared using the Discovery Studio Visualizer v 2.5, Accelrys Software Inc. 2009.
Statistical analysis
Data were analyzed with Student's t-test for variance. Experimental values are expressed as means ± S.D. The level of statistical significance was set at a level of p < 0.05.
Results

Isolation and purification of the natriuretic peptide from C. o. abyssus
Fractionation of the whole venom using gel filtration (Sephadex G-75) produced the elution profile shown in [5] . After ultrafiltration (cartridge UFP-10-C-MM01A, GE Healthcare), the filtrate was analyzed by Tricine SDS-PAGE electrophoresis and presented protein and peptides bands with molecular masses of around or smaller than 10 kDa. The filtrate decreased blood pressure and was further purified by C5-HPLC (Fig. 1B) . The RP-HPLC chromatography of filtrate demonstrated seven different peaks (or peak groups); all of these fractions were tested and just two showed activity by affecting blood pressure. One peak was identified as the Coa NP1 (natriuretic peptide 1 from C. o. abyssus) described by [5] . The second peak selected was denominated as Coa NP2 (Fig. 1B) . Both peptides are identified in the RP-HPLC chromatogram shown in Fig. 1 . Table 1 Multiple alignments using the amino acid sequence of Coa NP2 with other natriuretic peptides. 
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[41]); (6) H-ANP (human ANP), H-BNP (human BNP) and H-CNP (human CNP) (Schweitz et al. [33]).
The complete amino acid sequence of Coa NP2 was carried out by Edman degradation (Table 1 ) and average molecular mass (3419.88 Da) was confirmed by mass spectrometry (Fig. 2) . The theoretical average molecular mass was 3418.94 Da, monoisotopic molecular mass was 3416.66 Da and PI was 7.78.
The amino acid sequence of Coa NP presented the loop region that is characteristic of natriuretic peptides (17 amino acids -NP domain consensus = CFGxxxDRIxxxSGLGC) and presented 8 amino acid residue extensions following the NP domain in the sequence ( Table 1 ). The amino acid sequence of Coa NP2 was identified as: SYGISSGCFGLKLDRIGTMSGLGCWRLLQDSP (underlined sequence represents the domain consensus of the NPs). As expected for natriuretic-like peptides, the primary structure revealed two half cysteines, suggesting the presence of one disulfide bridge (Table 1) and belongs to the ANP/BNP-like family, since the carboxyterminal regions of c-natriuretic peptides (CNP) end in NP domains. The experimental results obtained in this study support the hypothesis that Coa NP2 is really a peptide of either the ANP or BNP families.
Rat blood pressure, nitric oxide plasma concentrations, and aortic rings natriuretic peptide isolated from C. o. abyssus venom (Coa NP2) effects
The natriuretic peptide isolated from C. o. abyssus venom (Coa NP2) caused a dose-dependent decrease in the median arterial pressure after its intravenous infusion (Fig. 3) .
We observed an increase in the production of plasma NOx (nitrate + nitrite) concentrations after the infusion of the Coa NP2, isolated from the C. o. abyssus venom (Fig. 4 ).
An increase in the production of plasma nitrite concentrations was also observed after Coa NP2 infusion, isolated from the C. o. abyssus venom (Fig. 5) .
Coa NP2 induced a relaxant effect on endothelium-intact thoracic aortic rings that were precontracted with phenylephrine in the absence and presence of ISATIN. Coa NP2 failed to relax endothelium-intact aortic rings that were precontracted with an isosmotic potassium Krebs-Henseleit solution (Fig. 6 ).
Theoretical model: computational methods
Unfortunately, when searching for homologous sequences (for the structural model of Coa NP2), using the Blast tool, no adequate sequences for ANP or BNP were found stored in the RCSB Protein Data Bank. The best homology (95%) was achieved with a CNP complexed with its receptor (1JDP) [16] . To better understand our structure, we removed the receptor from the global complex and used the CNP (GLSKGCFGLKLDRIGSMSGLGC) as a model, because its consensus domain is similar to that of the Coa NP2 (SYGISSGCFGLKLDRIGTMSGLGCWRLLQDSP). After applying the methods of molecular modeling and energy refinement, the most probable structure for Coa NP2 is shown in Fig. 7A.   Fig. 5 . Plasma nitrite concentrations (nM) after infusion of natriuretic peptide 2, isolated from C. o. abyssus (Coa NP2 venom). *p < 0.05 for Coa NP2 group, compared to the control group. Fig. 6 . Concentration-response curves (%) after infusion of natriuretic peptide 2 isolated from C. o. abyssus (Coa NP2 venom) on intact-endothelium (e + ) or denudedendothelium (e − ) thoracic aortic rings precontracted with phenylephrine (PE; 0.1 M). The relaxant effect evoked by Coa NP2 (10 −11 to 10 −7 M) was also compared on endothelium-intact tissues precontracted with PE (0.1 mM) and incubated with ISATIN (1 M), a natriuretic receptor A antagonist, 15 min before performing concentration-response curves to Coa NP2. The relaxant response was also evaluated in endothelium-intact rings precontracted with an isosmotic 80 mM potassium Krebs-Henseleit solution (K + 80). The results are expressed as the means ± S.D. of six independent experiments. *p < 0.05 vs. Coa NP2 intact endothelium group (Coa NP2 e + ).
The overlap of Coa NP2 after refinement and use of the CNP model is shown in Fig. 7B . The structural differences (RMSD 1.79Å) should be noted; these are probably related to the extensions of the portions C and N terminal Coa NP2 in relation to CNP. The overlap (RMSD 0.54Å) of Coa NP1 and Coa NP2 shows that both The alignment between the target and the template sequences showed a high similarity (95%). The models were then refined with the AMBER 9.0 package (optimized with 1000 steps of steep descent followed by 4000 steps of conjugate gradient). (C) Coa NP1 (red) superimposed on Coa NP2 (Green). The calculated RMSD is 0.54Å and this shows high similarity between both natriuretic peptides from C. o. abyssus. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.) 
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SKRLSNGCFGLKLDRIGAMSGLGCWRLINESK Coa_NP2 SYGISSGCFGLKLDRIGTMSGLGCWRLLQDSP * :* ***********:*********:::* molecules have very similar structures (Fig. 7C) . The comparative analysis between the sequences of Coa NP1 and Coa NP2 show a 90% homology approximately (Table 2) .
Discussion
This study describes the isolation of a new natriuretic peptide from C. o. abyssus venom (Coa NP2), whose primary structure was determined as SYGISSGCFGLKLDRIGTMSGLGCWRLLQDSP. Its purity and average molecular mass were confirmed by mass spectrometry as being 3419.88 Da (Fig. 2) (the theoretical average molecular mass is 3418.94 Da, monoisotopic molecular mass is 3416.66 Da and PI is 7.78). The primary structure revealed two half cysteines, suggesting the presence of one disulfide bridge.
Tertiary structure of Coa NP2 prevision, when compared to CNP (human), revealed a RMSD difference of 1.79Å and this effect is probably caused by the extension of the C-terminal of Coa NP2, but when compared to the structure of Coa NP1 [5] , the RMSD difference is only 0.54Å. It was expected because Coa NP1 and Coa NP2 sequences have homologies of around 90%.
We found that the natriuretic peptide isolated from C. o. abyssus venom (Coa NP2) presented a homologous structure to ANP and BNP. Furthermore, the mean functional findings of this present study were (i) the Coa NP2 produced a dose-dependent decrease in the mean arterial pressure (Coa NP2 infusion of 0.25 or 0.50 g/ml; Fig. 3) ; (ii) this hypotensive effect occurred along with a significant increase of nitric oxide formation in plasma (Figs. 4 and 5) ; and (iii) the vasorelaxation produced by the natriuretic peptide, Coa NP2, in thoracic aortic rings precontracted with phenylephrine was endothelium-dependent. As it was demonstrated by the vasorelaxation abolition in endothelium-denuded ring preparations (Fig. 6) , and (iv) Coa NP2 failed in induce aortic rings relax after precontract with 80 mM potassium (Fig. 6) .
Snakes venoms contain peptides with structural and functional equivalents of mammalian NPs (ANP, BNP and CNP), which present dose-dependent hypotensive effects [10, 34, 40] . In addition to natriuretic peptide studies, a 38-amino acid residues peptide (DNP) was isolated from the venom of Dendroaspis angusticeps (the green mamba snake), demonstrating properties that are similar to both human ANP and BNP [33] . Other NPs from snake venoms were identified from Lachesis muta (Lm-CNP), Bothrops jararacusu (Bj-CNP) and other snakes presenting a homologous structure for the human CNP [28, 35] .
The hypotensive effect of Coa NP2, presented herein, occurred in association with a significant increase in plasma nitrite levels, corroborating with previously data suggesting that NPs are able to stimulate nitric oxide (NO) production [4] . Together, a NO-dependent hypotensive effect was identified with a peptide isolated from the snake venom of Agkistrodon acutus [34] , and it was shown that infusion of NP isolated from Crotalus durissus cascavella venom was responsible for the increased nitrite levels [10] . Thus, these findings support the notion that Coa NP2 exerts its hypotensive action, at least in part, through stimulation of NO production.
As such, there are three different receptor isoforms for the NPs, namely, natriuretic peptide receptor A (NPR-A), natriuretic peptide receptor B (NPR-B), and natriuretic peptide receptor C (NPR-C), in which the human NP family have been shown natriuretic, diuretic, hypotensive and vasodilator actions [20, 22] . It has recently been suggested that BNP exerts its vascular effects through the same pathway as ANP, i.e. the NPR-A. This guanylate cyclase-coupled receptor is located both on endothelial and vascular smooth muscle cells [37] . Activation of NPR-A generates the second messenger cyclic guanosine monophosphate (cGMP) which, in turns, activates Ca 2+ channels and ATP-sensitive K + -channels leading to vasorelaxation [21, 29] . However, CNP binds to the NPR-B, a specific guanylate cyclase-coupled receptor, and it is located on the vascular smooth muscle cell, also leading to vasodilatation through hyperpolarization [19] .
To evaluate the possible mechanisms responsible for these dosedependent hypotensive effects, we used endothelium-denuded rings preparations (Coa NP2-e − ). It was observed that vasorelaxation produced by the Coa NP2 in thoracic aortic rings precontracted with phenylephrine was endothelium-dependent, as evidenced by its abolition when it was used Coa NP2-e − . (Coa NP2-e + or Coa NP2-e − group, respectively, Fig. 5 ). Similar findings were revealed by other NPs originated from different snake venoms [10, 38] .
The vasorelaxant effect caused by Coa NP2 seems not to be involved in the NP receptor type A (NPR-A). As the action verified of the Coa NP2 is not modified by addition of ISATIN (a potent guanylate cyclase-coupled NPR-A antagonist) in the aortae bath (Fig. 6 ), the failure of Coa NP2 to relax aortic rings precontracted with 80 mM potassium suggested a possible role for voltage-dependent ion channels that may include potassium channels; however, the primary mediator could be calcium influx, which activates a calcium-activated potassium channel and/or NO release [13] . Supporting this affirmation, the potassium-channel blocker, tetraethylammonium has been found to reduce the BNP-induced dilatation of brachial humans arteries [36] . As such, our findings demonstrate that the hypotension and vasodilatation caused by Coa NP2 is consistent with the hypothesis that both NPR-B pathways activate and stimulate NO production in parallel.
In conclusion, we isolated and characterized a new NP-like peptide from C. o. abyssus venom (Coa NP2), and we also report a dose-dependent hypotensive effect of this peptide in association with increased nitrite production, as well as vasodilatory endothelium-dependent effects. Therefore, these data suggest that the NO-release dependent vasodilator action of Coa NP2 may occur by stimulation of potassium channels.
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